Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rongbo Lin

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Seizure|June 25, 2025
Pediatric refractory epilepsy related to tuberous sclerosis complex: A retrospective-cohort study of diagnosis and treatmentRongbo Lin, Zhao Liao, Lingyu Kong, et al.
The Lancet. Respiratory Medicine|July 7, 2026
Ifebemtinib plus garsorasib as first-line treatment for KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trialZhengbo Song, Xingya Li, Rongbo Lin, et al.
Annals of Medicine|July 9, 2026
Randomized phase-II trial of surufatinib plus FOLFOX/FOLFIRI versus FOLFOXIRI as second-line therapy for metastatic colorectal cancerLiyu Su, Peicheng Lin, Yi Yin, et al.
Journal of Cancer|June 18, 2019
EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized LesionsYujie Deng, Xiaohui Chen, Chuanzhong Huang, et al.
Frontiers in Oncology|September 26, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancerShen Zhao, Liyu Su, Yigui Chen, et al.
Frontiers in Genetics|August 1, 2025
Case Report: A rare chromosomal imbalance with dup 7q36.3-qter and del 7pter-p22.3 arising from parental pericentric inversionRongbo Lin, Wenhui Zhang, Mingwei Huang, et al.
Seizure|December 27, 2025
The correlation between tuber burden and epilepsy onset in children with tuberous sclerosis complexZhanqi Hu, Xinyuan Chen, Ping Song, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II TrialRongbo Lin, Jinfeng Zhu, Yushuang Luo, et al.
Clinical Colorectal Cancer|December 4, 2024
Efficacy and Safety of KH903 Plus FOLFIRI as a Second-Line Treatment in Unresectable Recurrent or Metastatic Colorectal Cancer: A Randomized Phase 2 StudyJian Li, Y I Ba, Rongbo Lin, et al.
BMC Palliative Care|September 7, 2024
Efficacy and safety of fentanyl inhalant for the treatment of breakthrough cancer pain: a multicenter, randomized, double-blind, placebo-controlled trialRongbo Lin, Binbin Song, Na Li, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Seizure|June 25, 2025
Pediatric refractory epilepsy related to tuberous sclerosis complex: A retrospective-cohort study of diagnosis and treatmentRongbo Lin, Zhao Liao, Lingyu Kong, et al.
The Lancet. Respiratory Medicine|July 7, 2026
Ifebemtinib plus garsorasib as first-line treatment for KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trialZhengbo Song, Xingya Li, Rongbo Lin, et al.
Annals of Medicine|July 9, 2026
Randomized phase-II trial of surufatinib plus FOLFOX/FOLFIRI versus FOLFOXIRI as second-line therapy for metastatic colorectal cancerLiyu Su, Peicheng Lin, Yi Yin, et al.
Journal of Cancer|June 18, 2019
EZH2/Bcl-2 Coexpression Predicts Worse Survival in Diffuse Large B-cell Lymphomas and Demonstrates Poor Efficacy to Rituximab in Localized LesionsYujie Deng, Xiaohui Chen, Chuanzhong Huang, et al.
Frontiers in Oncology|September 26, 2022
Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancerShen Zhao, Liyu Su, Yigui Chen, et al.
Frontiers in Genetics|August 1, 2025
Case Report: A rare chromosomal imbalance with dup 7q36.3-qter and del 7pter-p22.3 arising from parental pericentric inversionRongbo Lin, Wenhui Zhang, Mingwei Huang, et al.
Seizure|December 27, 2025
The correlation between tuber burden and epilepsy onset in children with tuberous sclerosis complexZhanqi Hu, Xinyuan Chen, Ping Song, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 8, 2022
Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II TrialRongbo Lin, Jinfeng Zhu, Yushuang Luo, et al.
Clinical Colorectal Cancer|December 4, 2024
Efficacy and Safety of KH903 Plus FOLFIRI as a Second-Line Treatment in Unresectable Recurrent or Metastatic Colorectal Cancer: A Randomized Phase 2 StudyJian Li, Y I Ba, Rongbo Lin, et al.
BMC Palliative Care|September 7, 2024
Efficacy and safety of fentanyl inhalant for the treatment of breakthrough cancer pain: a multicenter, randomized, double-blind, placebo-controlled trialRongbo Lin, Binbin Song, Na Li, et al.
Pageof 5